Overview
Intestinal botulism is a severe paralytic illness caused by the ingestion of Clostridium botulinum toxins, leading to muscle paralysis, often affecting the gastrointestinal tract and potentially causing life-threatening complications such as respiratory failure and bowel obstruction 1.Diagnosis
Clinical Presentation: Characterized by progressive muscle weakness, blurred vision, difficulty swallowing, and in severe cases, respiratory distress 1.
Laboratory Tests: Elevated serum levels of intestinal fatty acid binding protein (I-FABP) can aid in diagnosing acute intestinal ischemia, which may coexist with or mimic intestinal botulism 4.
Imaging: Gastrointestinal ultrasound (GIUS) can be useful for diagnosing bowel obstruction, a potential complication, with sensitivity and specificity comparable to CT but superior to plain X-ray 1.
Other Markers: Consider evaluating for vitamin D levels, as deficiency may contribute to intestinal barrier dysfunction, although not directly diagnostic for botulism 2.Management
Antitoxin Administration: Administration of botulism antitoxin is critical for neutralizing circulating toxin 1.
Supportive Care: Includes mechanical ventilation for respiratory failure, nasogastric tube feeding for swallowing difficulties, and monitoring for complications like bowel obstruction 1.
Nutritional Support: Ensuring adequate nutritional support, possibly through parenteral nutrition if oral intake is severely compromised 1.
Monitoring: Close monitoring for signs of intestinal ischemia, utilizing markers like I-FABP for early detection 4.Special Populations
Pediatrics: Vitamin D deficiency may exacerbate intestinal injury in children, warranting assessment and supplementation if deficient 2.
Elderly: Increased risk of complications such as severe respiratory failure and prolonged recovery; close monitoring and supportive care are essential 1.Key Recommendations
Administer botulism antitoxin promptly upon suspicion to neutralize circulating toxin (Evidence: Strong 1).
Utilize gastrointestinal ultrasound for rapid assessment of bowel obstruction in suspected cases, considering its advantages over plain X-ray (Evidence: Moderate 1).
Monitor serum I-FABP levels in patients with suspected intestinal complications to aid in diagnosing acute ischemia (Evidence: Weak 4).
Evaluate and address vitamin D status in pediatric patients to support intestinal barrier function (Evidence: Moderate 2).References
1 Hollerweger A, Maconi G, Ripolles T, Nylund K, Higginson A, Serra C et al.. Gastrointestinal Ultrasound (GIUS) in Intestinal Emergencies - An EFSUMB Position Paper. Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2020. link
2 Lee C, Lau E, Chusilp S, Filler R, Li B, Zhu H et al.. Protective effects of vitamin D against injury in intestinal epithelium. Pediatric surgery international 2019. link
3 Avdeeva LV, Kharkhota MA, Nechypurenko OO. Fundamental Basis of Creation of Probiotic with Provitamin Activity Based on Strains Bacillus amyloliquefaciens IMV В-7513 and IMV B-7525. Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 2016. link
4 Kanda T, Fujii H, Fujita M, Sakai Y, Ono T, Hatakeyama K. Intestinal fatty acid binding protein is available for diagnosis of intestinal ischaemia: immunochemical analysis of two patients with ischaemic intestinal diseases. Gut 1995. link
5 Staun M, Sjöström H, Norén O. Calcium-binding protein from human small intestine. Purification and characterization of a 10,000 molecular weight protein. European journal of clinical investigation 1986. link
6 McDonald GB, Schuffler MD, Kadin ME, Tytgat GN. Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology 1985. link90587-6)